Dr. Swati Patel brings over two decades of dynamic leadership experience in steering the strategic transition of biotherapeutics for commercialization to the forefront of the biotech industry, with specialization in managing biologics discovery, development, assay validation, quality and regulations. Dr. Patel’s proficiency spans strategic management of bench-to-bedside transitions, understanding of clinical and translational research and meticulous oversight of biologics’ lifecycle, ensuring quality compliance aligned to stringent regulatory guidelines. Dr. Patel skillfully manages the complexities of biotherapeutics development through preclinical and clinical path. She excels in overseeing IND and clinical trial preparedness, steering the process, and establishing pivotal biomarkers. With a strong foundation as PhD in immunology and oncology from ACTREC, Tata Memorial Center, India and M.Sc. in Analytical and Medicinal Chemistry, University of Mumbai, she has led biotech innovations encompassing monoclonal antibodies, liposome-based therapies, and vaccine development. Dr. Patel boasts a proven track record encompassing successful drug development portfolio management, establishment of quality management system, and expertise in analytical/bioanalytical aspects for innovative biotech products, delivery systems and medical devices. Proficient across a spectrum of cutting-edge and traditional immunological and cellular techniques, her pursuit of scientific innovation is evident through record of her publications, and recognition from industry and academic institutions.